These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes. Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699 [TBL] [Abstract][Full Text] [Related]
4. Influences of alpha-tocopherol on cholesterol metabolism and fatty streak development in apolipoprotein E-deficient mice fed an atherogenic diet. Peluzio MC; Homem AP; Cesar GC; Azevedo GS; Amorim R; Cara DC; Saliba H; Vieira EC; Arantes RE; Alvarez-Leite J Braz J Med Biol Res; 2001 Dec; 34(12):1539-45. PubMed ID: 11717706 [TBL] [Abstract][Full Text] [Related]
5. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266 [TBL] [Abstract][Full Text] [Related]
6. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Dawson TC; Kuziel WA; Osahar TA; Maeda N Atherosclerosis; 1999 Mar; 143(1):205-11. PubMed ID: 10208497 [TBL] [Abstract][Full Text] [Related]
7. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Inoue S; Egashira K; Ni W; Kitamoto S; Usui M; Otani K; Ishibashi M; Hiasa K; Nishida K; Takeshita A Circulation; 2002 Nov; 106(21):2700-6. PubMed ID: 12438296 [TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Bea F; Blessing E; Bennett BJ; Kuo CC; Campbell LA; Kreuzer J; Rosenfeld ME Cardiovasc Res; 2003 Oct; 60(1):198-204. PubMed ID: 14522423 [TBL] [Abstract][Full Text] [Related]
10. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice. Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946 [TBL] [Abstract][Full Text] [Related]
11. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Tous M; Ferré N; Rull A; Marsillach J; Coll B; Alonso-Villaverde C; Camps J; Joven J Biochem Biophys Res Commun; 2006 Feb; 340(4):1078-84. PubMed ID: 16403442 [TBL] [Abstract][Full Text] [Related]
12. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice. Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741 [TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542 [TBL] [Abstract][Full Text] [Related]
14. Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats. Sato M; Shibata K; Nomura R; Kawamoto D; Nagamine R; Imaizumi K Br J Nutr; 2005 Dec; 94(6):896-901. PubMed ID: 16351765 [TBL] [Abstract][Full Text] [Related]
15. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Kowala MC; Recce R; Beyer S; Gu C; Valentine M Atherosclerosis; 2000 Apr; 149(2):323-30. PubMed ID: 10729382 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Bea F; Blessing E; Shelley MI; Shultz JM; Rosenfeld ME Atherosclerosis; 2003 Apr; 167(2):187-94. PubMed ID: 12818400 [TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Ni W; Kitamoto S; Ishibashi M; Usui M; Inoue S; Hiasa K; Zhao Q; Nishida K; Takeshita A; Egashira K Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):534-9. PubMed ID: 14739122 [TBL] [Abstract][Full Text] [Related]
18. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Chen YL; Chang YJ; Jiang MJ Atherosclerosis; 1999 Mar; 143(1):115-23. PubMed ID: 10208486 [TBL] [Abstract][Full Text] [Related]
19. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice]. Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357 [TBL] [Abstract][Full Text] [Related]
20. Characterization of monocyte chemoattractant proteins and CC chemokine receptor 2 expression during atherogenesis in apolipoprotein E-null mice. Zhang S; Wang X; Zhang L; Yang X; Pan J; Ren G J Atheroscler Thromb; 2011; 18(10):846-56. PubMed ID: 21712615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]